Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000938
Chunk: 62

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 62
---
i) any action for enforcement of this Agreement is commenced or is enforced by the Investor through any
legal proceeding; (ii) an attorney is retained to represent the Investor in any bankruptcy, reorganization, receivership or other proceedings
affecting creditors’ rights and involving a claim under this Agreement; or (iii) subject to hereof, an attorney
is retained to represent the Investor in any other proceedings whatsoever in connection with this Agreement, then the Company shall pay
to the Investor, as incurred by the Investor, all reasonable costs and expenses including reasonable attorneys’ fees incurred in
connection therewith, in addition to all other amounts due hereunder.

(o) . No provision of this Agreement may be amended other than by a written instrument signed
by both parties hereto and no provision of this Agreement may be waived other than in a written instrument signed by the party against
whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate
as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise
thereof or of any other right, power or privilege.

<div align='center'>** Signature Page Follows **</div>

| -35- |

IN WITNESS WHEREOF,
the Investor and the Company have caused this Agreement to be duly executed as of the Execution Date.

| THE COMPANY:                |                     |
| Biodexa Pharmaceuticals     
 Plc                         |                     |
| By:                         | /s/ Stephen Stamp   |
| Name:                       | Stephen Stamp       |
| Title:                      | President and CEO   |
| INVESTOR:                   |                     |
| C/M CAPITAL MASTER FUND, LP |                     |
| By:                         | /s/ Jonathan Juchno |
| Name:                       | Jonathan Juchno     |
| Title:                      | General Partner     |

| -36- |

<div align='center'>EXHIBITS</div>

| Exhibit A | Form of Officer’s Certificate |
| Exhibit B | Form of CFO’s Certificate     |
| Exhibit C | Form of Instruction Letter    |
| Exhibit D | Form of Purchase Notice       |

Exhibit 10.2

<div align='center'>REGISTRATION RIGHTS AGREEMENT</div>

THIS REGISTRATION RIGHTS AGREEMENT (this “”), dated as of January 17, 2025 (the “”), is entered
into by and between BIODEXA PHARMACEUT